BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules. The treatment suppressed tumors in mouse models of colon cancer and melanoma, and it worked even better when combined with checkpoint inhibiting drugs, they reported in a new study.

fiercebiotech.com